Danaher (NYSE:DHR) Trading Up 6.1% – Here’s What Happened

Danaher Corporation (NYSE:DHR) was up 6.1% during mid-day trading on Thursday . The stock traded as high as $189.04 and last traded at $189.9960. 3,009,031 shares changed hands during trading, a decline of 34% from the average session volume of 4,535,836 shares. The stock had previously closed at $179.14.

Danaher News Summary

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: J.P. Morgan reiterated a Buy rating on Danaher, which may help support investor confidence after the post-earnings pullback. J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
• Positive Sentiment: Several articles argue Danaher’s recent slump looks like an overreaction and could be a buying opportunity, suggesting the stock may recover if investors refocus on its long-term fundamentals. Here’s Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
• Positive Sentiment: Danaher’s quarterly results beat estimates, with EPS of $1.94 versus $1.85 expected and revenue of $6.27 billion above forecasts, which supports the case that core business performance remains solid. The ‘Standout Performance’ That Could Save Thermo Fisher, Danaher And Others
• Neutral Sentiment: Billionaire investor Dan Loeb reduced his Danaher stake in Q1 2026, adding to sentiment pressure around life sciences tools stocks, though it does not change Danaher’s operating results. Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
• Neutral Sentiment: Danaher saw unusually heavy put option activity, signaling traders are hedging against more downside in the near term. Don’t Quit on Danaher Stock After Horrific Earnings Reaction

Analyst Upgrades and Downgrades

Several brokerages have commented on DHR. Wells Fargo & Company lowered their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 target price on shares of Danaher in a report on Tuesday, April 21st. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday. Evercore restated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Finally, Rothschild & Co Redburn set a $205.00 price target on Danaher in a research report on Friday, April 17th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Stock Performance

The company has a market capitalization of $134.88 billion, a PE ratio of 34.08, a price-to-earnings-growth ratio of 2.40 and a beta of 0.79. The business’s fifty day moving average is $185.64 and its two-hundred day moving average is $197.04. The company has a current ratio of 1.65, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period last year, the business posted $0.77 EPS. The company’s revenue was up 5.5% compared to the same quarter last year. Equities research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is presently 28.42%.

Institutional Investors Weigh In On Danaher

Large investors have recently bought and sold shares of the business. Enterprise Financial Services Corp raised its position in Danaher by 1.4% in the 4th quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after buying an additional 46 shares during the last quarter. Kennebec Savings Bank boosted its holdings in shares of Danaher by 1.4% during the 4th quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after acquiring an additional 46 shares during the last quarter. Revolve Wealth Partners LLC raised its holdings in shares of Danaher by 2.6% during the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after purchasing an additional 47 shares during the last quarter. High Note Wealth LLC lifted its position in Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 47 shares during the period. Finally, First Command Advisory Services Inc. lifted its position in Danaher by 4.4% during the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after purchasing an additional 47 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.